Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5462)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2013 (publication date) through Jan 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Duca I, Piscina PRL, Estrada S, Calderón R, Spicakova K, Urtasun L, Marra-López C, Zabaleta S, Bengoa R, Marcaide MA, García-Campos F. Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab. World J Gastroenterol 2013; 19(4): 590-593 [PMID: 23382642 DOI: 10.3748/wjg.v19.i4.590] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i4/590.htm |
| Number | Citing Articles |
| 1 |
Stephan R. Vavricka, Martin Gubler, Claudine Gantenbein, Muriel Spoerri, Florian Froehlich, Frank Seibold, Marijana Protic, Pierre Michetti, Alex Straumann, Nicolas Fournier, Pascal Juillerat, Luc Biedermann, Jonas Zeitz, Benjamin Misselwitz, Michael Scharl, Henriette Heinrich, Christine N. Manser, Ekaterina Safroneeva, Raja Affendi Raja Ali, Gerhard Rogler, Alain M. Schoepfer, Thomas Greuter. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Inflammatory Bowel Diseases 2017; 23(7): 1174 doi: 10.1097/MIB.0000000000001109
|
| 2 |
Shana Rakowsky, Konstantinos Papamichael, Adam S. Cheifetz. Choosing the right biologic for complications of inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2022; 16(3): 235 doi: 10.1080/17474124.2022.2036122
|
| 3 |
|
| 4 |
Teresa Del Ross, Amelia Ruffatti, Annarosa Floreani, Ariela Hoxha, Leonardo Punzi. The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report. BMC Musculoskeletal Disorders 2016; 17(1) doi: 10.1186/s12891-016-1335-x
|
| 5 |
JIA-LE SONG, YU QIAN, GUI-JIE LI, XIN ZHAO. Anti-inflammatory effects of kudingcha methanol extract (Ilex kudingcha C.J. Tseng) in dextran sulfate sodium-induced ulcerative colitis. Molecular Medicine Reports 2013; 8(4): 1256 doi: 10.3892/mmr.2013.1635
|
| 6 |
Irene Franceschet, Nora Cazzagon, Teresa Del Ross, Renata D’Incà, Alessandra Buja, Annarosa Floreani. Primary sclerosing cholangitis associated with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(5): 508 doi: 10.1097/MEG.0000000000000596
|
| 7 |
Brigid Pinnuck, Kate D. Lynch. Navigating the pharmacotherapeutic management of comorbid inflammatory bowel disease and primary sclerosing cholangitis. Expert Opinion on Pharmacotherapy 2024; 25(13): 1835 doi: 10.1080/14656566.2024.2407022
|
| 8 |
Mitsuro Chiba, Hidehiko Tsuda, Satoko Tsuda, Masafumi Komatsu, Yasuo Horie, Hirohide Ohnishi. Normalization of Serum Alkaline Phosphatase in Primary Sclerosing Cholangitis Associated with Ulcerative Colitis. Health 2014; 6(10): 969 doi: 10.4236/health.2014.610122
|
| 9 |
Kate D. Lynch, Satish Keshav, Roger W. Chapman. The Use of Biologics in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. Current Hepatology Reports 2019; 18(1): 115 doi: 10.1007/s11901-019-00456-2
|